OptiNose (NASDAQ: OPTN) reported Q2 EPS of $0.02, $0.13 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $19.45 million versus the consensus estimate of $16.71 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.